Basilea Pharmaceutica has commenced next pharmacokinetic Phase 1 study with antibiotic BAL30072 in healthy volunteers. The injectable sulfactam antibiotic has the potential to target clinically relevant gram-negative bacteria resistant to ...
GE’s healthcare fund backs equity round in developer of combined near-infrared and ultrasonic blood and tissue monitor. CerOx probe Israel-based Ornim, a company developing a novel ...
Tags: Optical Brain Monitors, GE's healthcare fund, Israel-based Ornim
AbGenomics International, a biopharmaceutical company, has obtained FDA agreement on Its Phase 2 clinical trial plans of the novel autoimmune therapeutic candidate, AbGn-168H. The current Phase 2 AbGn-168H trial will be a multicenter, ...
Tags: FDA approval, psoriatic, clinical trial, pharmaceutical product